Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am Heart J. 2017 Jul 12;191:82–90. doi: 10.1016/j.ahj.2017.07.003

Table 5.

Clinical Characteristics of study sample by Tertiles of DBP Reactivity.

Characteristic (N=199) High Reactors
(N=63)		 Intermediate
Reactors (N=71)		 Low Reactors
(N=66)		 P value
Age (years) 56.6 ± 12.4 57.5 ± 12.7 56.6 ± 12.8 0.89
BMI (kg/m2) 31.0 ± 6.75 31.6 ± 7.60 31.3 ± 6.61 0.90
Race (% White) 52.4 50.8 47.0 0.82
Gender (% Female) 30.2 33.8 31.8 0.90
Pro BNP (pg/ml) 1236.1 ± 2023.0 1761.9 ± 3048.7 2127.6 ± 2887.9 0.17
LVEF (%) 33.3 ± 10.7 31.2 ± 12.3 32.3 ± 11.0a 0.49
Etiology (% ischemic) 38.1 46.5 45.5 0.58
Diabetes (%) 34.9 40.8 56.1a 0.04
Beta Blocker (%) 92.1 81.7 89.4 0.17
a

– significantly different from high reactors (p < .05);

b

– significantly different from intermediate reactors (p < .05);

c

– significantly different from low reactors (p < .05)